Launching a comparative effectiveness adaptive platform trial of monoclonal antibodies for COVID-19 in 21 days-Reference-Cited by-同舟云学术

Launching a comparative effectiveness adaptive platform trial of monoclonal antibodies for COVID-19 in 21 days

Published:2022-02 Issue: Volume:113 Page:106652
ISSN:1551-7144
Container-title:Contemporary Clinical Trials
language:en
Short-container-title:Contemporary Clinical Trials

Author:

McCreary Erin K.,Bariola J. Ryan,Minnier Tami,Wadas Richard J.,Shovel Judith A.,Albin Debbie,Marroquin Oscar C.,Schmidhofer Mark,Wisniewski Mary Kay,Nace David A.,Sullivan Colleen,Axe Meredith,Meyers Russell,Khadem Tina,Garrard William,Collins Kevin,Wells Alan,Bart Robert D.,Linstrum Kelsey,Montgomery Stephanie K.,Haidar Ghady,Snyder Graham M.,McVerry Bryan J.,Seymour Christopher W.,Yealy Donald M.,Huang David T.,Angus Derek C.

Publisher

Elsevier BV

Subject

Pharmacology (medical),General Medicine

Reference13 articles.

1. Equitable pandemic preparedness and rapid response: lessons from COVID-19 for pandemic health equity;Alberti;J. Health Polit. Policy Law,2020

2. SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with COVID-19;Chen;N. Engl. J. Med.,2021

3. REGN-COV2, a neutralizing antibody cocktail, in outpatients with COVID-19;Weinreich;N. Engl. J. Med.,2021

4. Effect of bamlanivimab as monotherapy or in combination with Etesevimab on viral load in patients with mild to moderate COVID-19: a randomized clinical trial;Gottlieb;Jama,2021

5. Impact of monoclonal antibody treatment on hospitalization and mortality among non-hospitalized adults with SARS-CoV-2 infection;Bariola;medRxiv,2021

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Our “Side Hustle”;Clinical Infectious Diseases;2023-10-04

2. Designing and Implementing “Living and Breathing” Clinical Trials;Critical Care Clinics;2023-10

3. Monoclonal Antibodies for the Treatment of COVID-19—Every Day You Fight Like You’re Running Out of Time;JAMA Network Open;2023-04-24

4. Monoclonal Antibodies for Treatment of SARS-CoV-2 Infection During Pregnancy;Annals of Internal Medicine;2022-12

5. Evaluation of Bebtelovimab for Treatment of Covid-19 During the SARS-CoV-2 Omicron Variant Era;Open Forum Infectious Diseases;2022-10-01